Discussion about this post

User's avatar
Richard Sharpe's avatar

On a kind of related topic, I came across these two papers recently which essentially explain why the modRNA vaccines cannot prevent the spread of the SARS-CoV-2 virus (note, I am not saying anything about whether they affect severity of the disease.)

Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses

https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(22)00572-8

Authors include Fauci and it is from 2022/2023.

"In this review, we examine challenges that have impeded development of effective mucosal respiratory vaccines, emphasizing that all of these viruses replicate extremely rapidly in the surface epithelium and are quickly transmitted to other hosts, within a narrow window of time before adaptive immune responses are fully marshaled."

SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming

https://www.cell.com/cell/fulltext/S0092-8674(22)01505-7

Published a little before the one above. Authors from Standford.

This article provides exquisite descriptions of the mechanisms of entry and exit for various respiratory viruses and seems above reproach.

PAK1 blockers would seem to be useful, and D3 and IVM are PAK1 blockers but you can search for articles on those.

Expand full comment
Richard Sharpe's avatar

I had never heard of diphtheria until moving to the US, but then I lived in fairly spread out areas in Australia for my first 19 years. That is none of them had large populations. Also, there seemed to be no knowledge about it.

However, I just asked a person from Hong Kong if they had heard of it (or the Chinese name for it) and she had not. Also, a quick search revealed no info on the history of diphtheria in China, which is strange because they have had very large cities for quite a while and HK has been a large city for quite some time. Maybe opium was a bigger problem for them.

Expand full comment
9 more comments...

No posts